Investigation and treatment of dry eyes.


Management of dry eye syndrome typically involves addressing the underlying causes, managing symptoms, and improving tear production or quality.

Example dry eye report

Dry Eye Investigation & Assessment

Understanding the cause of your dry eye

Effective treatment starts with an accurate diagnosis.

Dry eye is not a single condition — it is a combination of:

  • Tear film instability

  • Inflammation

  • Meibomian gland dysfunction

  • Ocular surface damage

Our assessments are designed to identify which of these is affecting you, so we can deliver the most effective treatment.


Dry Eye Investigation & Assessment

Understanding the Cause of Your Dry Eye

Effective treatment starts with an accurate diagnosis.

Dry eye is not a single condition. It is often caused by a combination of:

  • Tear film instability

  • Inflammation

  • Meibomian gland dysfunction

  • Ocular surface damage

Our assessments are designed to identify the underlying causes of your symptoms, allowing us to create a personalised treatment plan focused on long-term improvement rather than temporary relief.


Advanced Dry Eye Assessment — £250

Including Laboratory Biomarkers

Our most comprehensive dry eye evaluation, designed for patients seeking the most detailed understanding of their condition.

This assessment combines advanced imaging, tear film analysis and laboratory biomarker testing to provide a complete picture of ocular surface health.


Includes:

Detailed Clinical Consultation

A thorough review of your symptoms, medical history, lifestyle factors and previous treatments.

Meibomian Gland Imaging (Meibography)

Infrared imaging used to assess gland structure and survival.

Why it matters: Healthy glands are essential for producing the oil layer of the tear film. Gland loss can significantly affect long-term comfort and treatment outcomes.

Meibomian Gland Opening Analysis

High-definition imaging of the eyelid margins to identify gland blockage (capping).

Why it matters: Blocked glands prevent healthy oil flow and are a major cause of evaporative dry eye.

Ocular Redness Analysis

Automated imaging that measures blood vessel activity and inflammation.

Why it matters: Chronic inflammation is often a key driver of dry eye symptoms.

Corneal Staining Analysis

Assessment of ocular surface damage using fluorescein dye.

Why it matters: Identifies areas where the tear film is failing to adequately protect the eye.

Tearscope Lipid Layer Analysis

Evaluation of the oil layer of the tear film.

Why it matters: A poor-quality lipid layer leads to rapid tear evaporation and unstable vision.

Tear Meniscus Height

Measurement of tear volume.

Why it matters: Helps determine whether inadequate tear production is contributing to symptoms.

Non-Invasive Tear Break-Up Time (NITBUT)

Assessment of tear film stability.

Why it matters: Measures how long tears remain effective before evaporating.

Exploratory Meibomian Gland Expression

Assessment of gland function, oil quality and treatment potential.

Why it matters: Helps determine gland viability and likelihood of recovery.


Advanced Biomarker Analysis

Laboratory biomarker testing helps identify the inflammatory processes driving your condition.

These markers provide additional insight into:

  • Ocular surface inflammation

  • Allergic eye disease

  • Chronic immune-mediated dry eye

  • Disease severity and progression

This information allows treatment recommendations to be tailored more precisely to your individual condition.


Your Personalised Report

Following your assessment, you will receive a detailed report including:

  • Dry eye diagnosis and subtype classification

  • Clinical images and findings

  • Biomarker results and interpretation

  • Identification of underlying causes

  • Personalised treatment recommendations

Outcome

A tailored treatment plan designed specifically for your eyes and your symptoms.

Clinical Dry Eye Assessment — £150

A detailed clinical evaluation without laboratory biomarker testing.

Suitable for:

  • Mild to moderate dry eye symptoms

  • Initial investigations

  • Patients not requiring advanced biomarker analysis

Includes:

  • Detailed symptom assessment

  • Meibomian gland imaging

  • Meibomian gland opening analysis

  • Ocular redness analysis

  • Corneal staining analysis

  • Tearscope lipid layer assessment

  • Tear meniscus height measurement

  • Non-invasive tear break-up time

  • Exploratory gland expression

  • Personalised report and treatment recommendations

From Diagnosis to Treatment

Once we understand the cause of your symptoms, we move into a structured treatment pathway designed to address the underlying disease process.

Reduce → Clear → Restore

Reduce Inflammation

IPL (Intense Pulsed Light)

Targets inflammation and improves the environment surrounding the meibomian glands.

Clear Obstruction

Meibomian Gland Expression

Performed immediately following IPL treatment to clear blocked glands and restore oil flow.

Restore Function

QMR (Quantum Molecular Resonance)

Supports cellular repair, gland recovery and long-term improvement in tear film quality.

Together, these treatments provide a comprehensive approach to managing dry eye disease and meibomian gland dysfunction.

Our Goal

  • Reduce symptoms

  • Improve tear film stability

  • Restore gland function

  • Improve long-term ocular surface health

  • Reduce dependence on lubricating eye drops

Ready to Start?

Book your Advanced Dry Eye Assessment and begin your personalised journey towards lasting dry eye relief.